Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (41-50 of 368) with videos related to

Pageof 37
Sort By:
Social Science & Medicine (1982)|May 14, 2025
Professional identities and new technologies of hepatitis C point-of-care testingAnna Conway, Alison D Marshall, Jason Grebely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2005
A systematic approach to the treatment of HIV and hepatitis C virus infection in the inner city: a Canadian perspectiveBrian Conway, Jason Grebely, Harout Tossonian, et al.
Hepatology (Baltimore, Md.)|August 10, 2013
Disease progression during advanced fibrosis: IL28B genotype or HCV RNA levels?Jason Grebely, Bart Grady, Behzad Hajarizadeh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2013
Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirementsJason Grebely, Gail V Matthews, Andrew R Lloyd, et al.
Current HIV/AIDS Reports|April 23, 2017
HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject DrugsMarianne Martinello, Behzad Hajarizadeh, Jason Grebely, et al.
Drug and Alcohol Dependence|January 4, 2011
Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugsCarla Treloar, Peter Hull, Joanne Bryant, et al.
Nature Reviews. Gastroenterology & Hepatology|May 19, 2018
Management of acute HCV infection in the era of direct-acting antiviral therapyMarianne Martinello, Behzad Hajarizadeh, Jason Grebely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Directly observed pegylated interferon plus self-administered ribavirin for the treatment of hepatitis C virus infection in people actively using drugs: a randomized controlled trialRobert J Hilsden, Gisela Macphail, Jason Grebely, et al.
Canadian Liver Journal|August 22, 2022
The role of prevention strategies in achieving HCV elimination in Canada: what are the remaining challenges?Stine Bordier Høj, Nanor Minoyan, Andreea Adelina Artenie, et al.
Addiction (Abingdon, England)|July 11, 2018
Competing global statistics on prevalence of injecting drug use: why does it matter and what can be done?Matt Hickman, Sarah Larney, Amy Peacock, et al.
Pageof 37

Showing results (41-50 of 368) with videos related to

Sort By:
Pageof 37
Social Science & Medicine (1982)|May 14, 2025
Professional identities and new technologies of hepatitis C point-of-care testingAnna Conway, Alison D Marshall, Jason Grebely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2005
A systematic approach to the treatment of HIV and hepatitis C virus infection in the inner city: a Canadian perspectiveBrian Conway, Jason Grebely, Harout Tossonian, et al.
Hepatology (Baltimore, Md.)|August 10, 2013
Disease progression during advanced fibrosis: IL28B genotype or HCV RNA levels?Jason Grebely, Bart Grady, Behzad Hajarizadeh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2013
Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirementsJason Grebely, Gail V Matthews, Andrew R Lloyd, et al.
Current HIV/AIDS Reports|April 23, 2017
HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject DrugsMarianne Martinello, Behzad Hajarizadeh, Jason Grebely, et al.
Drug and Alcohol Dependence|January 4, 2011
Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugsCarla Treloar, Peter Hull, Joanne Bryant, et al.
Nature Reviews. Gastroenterology & Hepatology|May 19, 2018
Management of acute HCV infection in the era of direct-acting antiviral therapyMarianne Martinello, Behzad Hajarizadeh, Jason Grebely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Directly observed pegylated interferon plus self-administered ribavirin for the treatment of hepatitis C virus infection in people actively using drugs: a randomized controlled trialRobert J Hilsden, Gisela Macphail, Jason Grebely, et al.
Canadian Liver Journal|August 22, 2022
The role of prevention strategies in achieving HCV elimination in Canada: what are the remaining challenges?Stine Bordier Høj, Nanor Minoyan, Andreea Adelina Artenie, et al.
Addiction (Abingdon, England)|July 11, 2018
Competing global statistics on prevalence of injecting drug use: why does it matter and what can be done?Matt Hickman, Sarah Larney, Amy Peacock, et al.
Pageof 37